YOLFTbeta
60

Zhejiang Ausun Pharmaceutical Co Ltd

603229 · SHG · Healthcare / Biotechnology

6.82CNY-0.19 (-2.71%)

Price History

Full chart

Market Stats

Previous Close7.01
Open6.98
Day Range6.78 – 7.01
52-Week Range7.15 – 10.81
Volume5.43M
Market Cap6.86B
P/E (TTM)75.09
Forward P/E0.00
EPS0.11
Dividend Yield0.77%
Beta-0.18
50-Day Avg7.88
200-Day Avg9.10

About

Zhejiang Ausun Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical formulations, specialty active pharmaceutical ingredients (APIs), and pharmaceutical intermediates in China and internationally. The company offers products for liver diseases, respiratory system diseases, cardiovascular and cerebrovascular diseases, high-end fluorine products, prostaglandins, antibacterial agents, gout, anti-tumor treatments, and nervous system disorders. It also provides customized contract research, development, and manufacturing services. In addition, the company engages in technology research and development, commissioned technology development, technology transfer, consulting, and promotion services; wholesale of organic intermediates; medical research and experimental development; market research; conference services; organization of exhibitions and displays; import and export trade of pharmaceuticals, food, cosmetics, medical devices, goods and technology, and related instruments and equipment; drug clinical trials; retail of pharmaceuticals; technical consultation and exchange; health consultation; and research and development of biochemical products. Zhejiang Ausun Pharmaceutical Co., Ltd. was incorporated in 2010 and is headquartered in Taizhou, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Zhiguo Zheng
  • Employees1.33K
  • HeadquartersNo. 5 Donghai Fourth Lane, Taizhou, China, 317016, China
  • Websitehttps://www.ausunpharm.com

Leadership

  • Mr. Zhiguo ZhengChairman & GM · b. 1971
  • Mr. Kai GaoDeputy General Manager · b. 1981
  • Ms. Yu ZhongDeputy General Manager · b. 1962

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue58.93M120.95M201.42M262.67M198.84M240.19M243.89M307.91M409.25M569.70M764.55M816.77M795.29M792.76M
Growth (%)-+105.24%+66.53%+30.41%-24.30%+20.79%+1.54%+26.25%+32.91%+39.21%+34.20%+6.83%-2.63%-0.32%
Cost of Revenue43.34M65.97M93.80M128.14M89.99M98.88M138.27M156.46M182.58M261.29M372.58M372.41M373.39M368.56M
Gross Profit15.59M54.97M107.62M134.53M108.85M141.31M105.61M151.46M226.67M308.41M391.96M444.36M421.90M424.20M
Gross Margin26.46%45.45%53.43%51.22%54.74%58.83%43.30%49.19%55.39%54.14%51.27%54.40%53.05%53.51%
Operating Expense10.13M31.57M80.90M69.23M46.24M81.02M58.37M90.35M130.05M148.26M134.25M153.53M180.76M285.57M
Operating Income5.47M23.40M26.72M65.29M62.61M60.29M47.24M61.11M96.61M160.15M257.71M290.82M241.14M138.63M
Operating Margin9.28%19.35%13.27%24.86%31.49%25.10%19.37%19.85%23.61%28.11%33.71%35.61%30.32%17.49%
EBITDA8.95M31.37M42.77M77.92M74.46M87.56M43.69M66.94M134.32M182.22M239.68M285.14M248.24M220.18M
EBITDA Margin15.19%25.94%21.23%29.67%37.45%36.45%17.91%21.74%32.82%31.99%31.35%34.91%31.21%27.77%
Net Income2.29M15.55M21.50M60.87M57.33M53.01M43.86M56.39M86.84M145.93M235.38M253.90M206.79M130.57M
Net Income Margin3.89%12.86%10.67%23.17%28.83%22.07%17.99%18.31%21.22%25.62%30.79%31.09%26.00%16.47%
R&D4.11M13.95M26.92M31.46M23.48M29.84M34.37M47.75M50.77M68.82M67.07M78.06M100.42M167.89M
R&D as % of Total Revenue6.97%11.54%13.37%11.98%11.81%12.42%14.09%15.51%12.41%12.08%8.77%9.56%12.63%21.18%
Interest Expense--5.13M4.34M3.13M2.70M3.21M2.71M1.60M1.47M6.55M8.27M8.03M8.09M
Interest Expense % of Total Revenue--2.55%1.65%1.58%1.12%1.32%0.88%0.39%0.26%0.86%1.01%1.01%1.02%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets122.57M178.78M260.11M401.89M446.06M741.58M801.98M886.14M1.38B1.84B2.32B2.95B2.98B3.09B
Total Liabilities112.21M145.87M181.90M213.81M202.76M176.65M204.38M240.96M254.81M584.64M854.19M809.99M710.50M815.89M
Total Equity10.36M32.91M78.21M188.07M243.30M564.93M597.60M645.19M1.13B1.25B1.46B2.14B2.27B2.27B
Cash3.27M7.87M8.82M58.21M109.49M240.39M278.04M341.54M739.11M564.55M608.85M1.12B1.10B1.22B
Total Debt49.50M70.50M75.64M54.88M60.60M62.49M72.00M44.96M41.04M109.93M242.02M302.30M271.39M-
Net Debt46.23M62.63M66.82M-3.33M-48.89M-177.90M-206.04M-296.58M-698.06M-454.62M-366.83M-821.93M-824.90M-

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.14M15.73M21.45M53.63M93.21M46.78M11.50M87.73M138.47M173.90M120.57M221.85M177.93M156.51M
Investing Cash Flow-31.53M-36.64M-20.95M-41.68M-40.95M-111.51M-36.68M-2.21M-105.44M-432.30M-177.85M-175.47M-119.97M-
Financing Cash Flow28.04M23.60M98.08K24.01M212.20K202.43M57.83M-38.45M390.20M37.03M94.92M469.93M-108.22M-
Capital Expenditure37.54M36.71M23.08M42.80M42.79M54.36M55.05M49.63M92.95M310.85M271.91M163.47M111.30M104.45M
Free Cash Flow-38.68M-20.98M-1.63M10.82M50.42M-7.58M-43.55M38.10M45.52M-136.95M-151.35M58.38M66.62M52.06M
Dividends Paid2.46M4.40M5.04M4.23M5.51M2.97M14.17M8.80M12.00M17.94M29.28M57.45M84.22M90.62M
FCF to OCF3397.84%-133.37%-7.61%20.18%54.09%-16.20%-378.58%43.43%32.87%-78.75%-125.53%26.31%37.44%33.27%
Dividend Paid to FCF-6.37%-20.96%-309.03%39.04%10.92%-39.15%-32.54%23.09%26.36%-13.10%-19.35%98.41%126.40%174.06%

Earnings

Report DateApr 15, 2017Aug 30, 2017Oct 31, 2017Dec 31, 2017Apr 11, 2018Aug 30, 2018Oct 30, 2018Dec 31, 2018Apr 11, 2019Aug 28, 2019Oct 30, 2019Dec 31, 2019Apr 30, 2020Jul 17, 2020Oct 30, 2020Dec 31, 2020Apr 28, 2021Aug 18, 2021Oct 25, 2021Dec 31, 2021Apr 19, 2022Aug 29, 2022Oct 30, 2022Dec 31, 2022Apr 27, 2023
EPS Estimate0.00------------------------
EPS Actual0.100.090.050.040.130.140.050.020.070.150.120.010.040.140.060.040.180.110.070.060.250.130.130.100.15
Surprise-------------------------
TimingAfter-hoursPre-market--------After-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hours-Pre-market

Key Statistics & Ratios

Market Cap6.86B
Enterprise Value6.33B
Trailing P/E75.09
Forward P/E0.00
Price / Sales8.81
Price / Book2.92
EPS0.11
Book Value2.90
Revenue (TTM)778.50M
Gross Profit (TTM)376.54M
EBITDA145.64M
Profit Margin10.41%
Operating Margin-4.37%
Return on Equity3.37%
Return on Assets1.32%
Shares Outstanding830.30M
Shares Float372.45M
Beta-0.18
Dividend Yield0.77%
Dividend Rate0.06
Payout Ratio90.91%

Dividends

20231×
0.11Jul 12, 2023
20221×
0.07May 26, 2022
20211×
0.04Jul 6, 2021
20201×
0.03Jun 23, 2020
20191×
0.02Jun 14, 2019
20181×
0.02Jun 13, 2018

Stock Splits

  • Jul 12, 20237:5
  • May 26, 20227:5
  • Jul 6, 20216:5
  • Jun 23, 20207:5